97 related articles for article (PubMed ID: 10527879)
1. Residues within the HFRIGC sequence of HIV-1 vpr involved in growth arrest activities.
Berglez JM; Castelli LA; Sankovich SA; Smith SC; Curtain CC; Macreadie IG
Biochem Biophys Res Commun; 1999 Oct; 264(1):287-90. PubMed ID: 10527879
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle inhibitory effects of HIV and SIV Vpr and Vpx in the yeast Schizosaccharomyces pombe.
Zhang C; Rasmussen C; Chang LJ
Virology; 1997 Mar; 230(1):103-12. PubMed ID: 9126266
[TBL] [Abstract][Full Text] [Related]
3. Role of the conserved dipeptide Gly75 and Cys76 on HIV-1 Vpr function.
Mahalingam S; Collman RG; Patel M; Monken CE; Srinivasan A
Virology; 1995 Jul; 210(2):495-500. PubMed ID: 7618286
[TBL] [Abstract][Full Text] [Related]
4. Arginine residues in the C-terminus of HIV-1 Vpr are important for nuclear localization and cell cycle arrest.
Zhou Y; Lu Y; Ratner L
Virology; 1998 Mar; 242(2):414-24. PubMed ID: 9514978
[TBL] [Abstract][Full Text] [Related]
5. Identification of residues in the N-terminal acidic domain of HIV-1 Vpr essential for virion incorporation.
Mahalingam S; Khan SA; Jabbar MA; Monken CE; Collman RG; Srinivasan A
Virology; 1995 Feb; 207(1):297-302. PubMed ID: 7871742
[TBL] [Abstract][Full Text] [Related]
6. The carboxy-terminal domain is essential for stability and not for virion incorporation of HIV-1 Vpr into virus particles.
Mahalingam S; Patel M; Collman RG; Srinivasan A
Virology; 1995 Dec; 214(2):647-52. PubMed ID: 8553570
[TBL] [Abstract][Full Text] [Related]
7. A carboxy-terminally truncated form of the Vpr protein of human immunodeficiency virus type 1 retards cell proliferation independently of G(2) arrest of the cell cycle.
Nishizawa M; Myojin T; Nishino Y; Nakai Y; Kamata M; Aida Y
Virology; 1999 Oct; 263(2):313-22. PubMed ID: 10544105
[TBL] [Abstract][Full Text] [Related]
8. Transactivation is a conserved function among primate lentivirus Vpr proteins but is not shared by Vpx.
Philippon V; Matsuda Z; Essex M
J Hum Virol; 1999; 2(3):167-74. PubMed ID: 10413368
[TBL] [Abstract][Full Text] [Related]
9. Analysis of HIV-1 Vpr determinants responsible for cell growth arrest in Saccharomyces cerevisiae.
Yao XJ; Rougeau N; Duisit G; Lemay J; Cohen EA
Retrovirology; 2004 Aug; 1():21. PubMed ID: 15312229
[TBL] [Abstract][Full Text] [Related]
10. Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication.
Thotala D; Schafer EA; Tungaturthi PK; Majumder B; Janket ML; Wagner M; Srinivasan A; Watkins S; Ayyavoo V
Virology; 2004 Oct; 328(1):89-100. PubMed ID: 15380361
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis by the Vpr protein of human immunodeficiency virus type 1 occurs independently of G(2) arrest of the cell cycle.
Nishizawa M; Kamata M; Mojin T; Nakai Y; Aida Y
Virology; 2000 Oct; 276(1):16-26. PubMed ID: 11021990
[TBL] [Abstract][Full Text] [Related]
12. NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: molecular insights into its biological functions.
Schüler W; Wecker K; de Rocquigny H; Baudat Y; Sire J; Roques BP
J Mol Biol; 1999 Feb; 285(5):2105-17. PubMed ID: 9925788
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway.
Yoshizuka N; Yoshizuka-Chadani Y; Krishnan V; Zeichner SL
J Virol; 2005 Sep; 79(17):11366-81. PubMed ID: 16103188
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of HIV-1 Vpr: identification of determinants essential for subcellular localization.
Mahalingam S; Collman RG; Patel M; Monken CE; Srinivasan A
Virology; 1995 Oct; 212(2):331-9. PubMed ID: 7571402
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro.
Vanitharani R; Mahalingam S; Rafaeli Y; Singh SP; Srinivasan A; Weiner DB; Ayyavoo V
Virology; 2001 Oct; 289(2):334-42. PubMed ID: 11689055
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect.
Yao XJ; Kobinger G; Dandache S; Rougeau N; Cohen E
Gene Ther; 1999 Sep; 6(9):1590-9. PubMed ID: 10490769
[TBL] [Abstract][Full Text] [Related]
17. Establishment of latent HIV-1 infection of resting CD4(+) T lymphocytes does not require inactivation of Vpr.
Shen A; Siliciano JD; Pierson TC; Buck CB; Siliciano RF
Virology; 2000 Dec; 278(1):227-33. PubMed ID: 11112497
[TBL] [Abstract][Full Text] [Related]
18. A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects.
Macreadie IG; Castelli LA; Hewish DR; Kirkpatrick A; Ward AC; Azad AA
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2770-4. PubMed ID: 7708721
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).
Gleenberg IO; Herschhorn A; Hizi A
J Mol Biol; 2007 Jun; 369(5):1230-43. PubMed ID: 17490682
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic effects of HIV-1 protein R (Vpr) on morphogenesis and cell survival in fission yeast and antagonism by pentoxifylline.
Zhao Y; Yu M; Chen M; Elder RT; Yamamoto A; Cao J
Virology; 1998 Jul; 246(2):266-76. PubMed ID: 9657945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
